Abstract
The domestic cat (Felis catus) numbers over 94 million in the USA alone, occupies households as a companion animal, and, like humans, suffers from cancer and common and rare diseases. However, genome-wide sequence variant information is limited for this species. To empower trait analyses, a new cat genome reference assembly was developed from PacBio long sequence reads that significantly improve sequence representation and assembly contiguity. The whole genome sequences of 54 domestic cats were aligned to the reference to identify single nucleotide variants (SNVs) and structural variants (SVs). Across all cats, 16 SNVs predicted to have deleterious impacts and in a singleton state were identified as high priority candidates for causative mutations. One candidate was a stop gain in the tumor suppressor FBXW7. The SNV is found in cats segregating for feline mediastinal lymphoma and is a candidate for inherited cancer susceptibility. SV analysis revealed a complex deletion coupled with a nearby potential duplication event that was shared privately across three unrelated cats with dwarfism and is found within a known dwarfism associated region on cat chromosome B1. This SV interrupted UDP-glucose 6-dehydrogenase (UGDH), a gene involved in the biosynthesis of glycosaminoglycans. Importantly, UGDH has not yet been associated with human dwarfism and should be screened in undiagnosed patients. The new high-quality cat genome reference and the compilation of sequence variation demonstrate the importance of these resources when searching for disease causative alleles in the domestic cat and for identification of feline biomedical models.
Highlights
IntroductionThe practice of genomic medicine is impending [1]
In the veterinary clinic, the practice of genomic medicine is impending [1]
The practice of genomic medicine is predicated on the availability of a high quality reference genome and an understanding of the impact of genome variation
Summary
The practice of genomic medicine is impending [1]. With actionable genetic information in hand, companion animal therapeutic interventions are feasible, including treatment of animal patients prior to, or to prevent the appearance of, more severe symptoms and allow therapeutic administration of drugs with higher efficacy and fewer side effects. Genomic information can alert veterinarians to imminent disease risks for diagnostic consideration. Each of these applications could significantly enhance veterinary medicine, none are currently in practice. Targeted individual companion animal genome information is becoming more readily available, cost effective, and tentatively linked to the actionable phenotypes via direct-to-consumer DNA testing. Correct interpretation of DNA variants is of the utmost importance for communicating findings to clinicians practicing companion animal genomic medicine [5]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.